Skip to content
Wenlo
Sign in
← Markets

Regeneron Pharmaceuticals, Inc.

Marion McCourt (EVP Commercial) sells REGN shares

4REGNFiled Nov 18, 2026, 4:10 PM ET· Period Nov 16, 2026

AI-generated summary

Marion McCourt, EVP Commercial, sold 566 shares of Common Stock directly for $543,504.06 at an average price of $960.25 on November 16, 2026. After these transactions, the insider directly held 10,305 shares. The transactions were executed under a Rule 10b5-1 trading plan adopted on February 17, 2026.

Key facts

Insider
Marion McCourt · EVP Commercial

Rule 10b5-1 plan · adopted Feb 17, 2026

DateTransactionSharesPriceValueHeld afterOwnership
Nov 16, 2026S · open-market saleFootnotes F1, F2−44$952.79$41,922.7610,827Direct
Nov 16, 2026S · open-market saleFootnotes F1, F3−59$954.46$56,313.1410,768Direct
Nov 16, 2026S · open-market saleFootnotes F1−30$955.51$28,665.3010,738Direct
Nov 16, 2026S · open-market saleFootnotes F1−22$956.01$21,032.2210,716Direct
Nov 16, 2026S · open-market saleFootnotes F1, F4−44$958.47$42,172.6810,672Direct
Nov 16, 2026S · open-market saleFootnotes F1, F5−66$959.46$63,324.3610,606Direct
Nov 16, 2026S · open-market saleFootnotes F1, F6−49$960.31$47,055.1910,557Direct
Nov 16, 2026S · open-market saleFootnotes F1, F7−59$961.36$56,720.2410,498Direct
Nov 16, 2026S · open-market saleFootnotes F1, F8−41$962.44$39,460.0410,457Direct
Nov 16, 2026S · open-market saleFootnotes F1, F9−42$963.70$40,475.4010,415Direct
Nov 16, 2026S · open-market saleFootnotes F1−21$964.69$20,258.4910,394Direct
Nov 16, 2026S · open-market saleFootnotes F1, F10−63$965.62$60,834.0610,331Direct
Nov 16, 2026S · open-market saleFootnotes F1−26$971.93$25,270.1810,305Direct
Footnotes
  1. F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026.
  2. F2 Represents volume-weighted average price of sales of 44 shares of Company stock on November 16, 2026 at prices ranging from $952.64 to $952.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  3. F3 Represents volume-weighted average price of sales of 59 shares of Company stock on November 16, 2026 at prices ranging from $954.44 to $954.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  4. F4 Represents volume-weighted average price of sales of 44 shares of Company stock on November 16, 2026 at prices ranging from $958.29 to $958.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  5. F5 Represents volume-weighted average price of sales of 66 shares of Company stock on November 16, 2026 at prices ranging from $959.18 to $959.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  6. F6 Represents volume-weighted average price of sales of 49 shares of Company stock on November 16, 2026 at prices ranging from $960.07 to $960.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  7. F7 Represents volume-weighted average price of sales of 59 shares of Company stock on November 16, 2026 at prices ranging from $961.26 to $961.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  8. F8 Represents volume-weighted average price of sales of 41 shares of Company stock on November 16, 2026 at prices ranging from $962.15 to $962.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  9. F9 Represents volume-weighted average price of sales of 42 shares of Company stock on November 16, 2026 at prices ranging from $963.32 to $963.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
  10. F10 Represents volume-weighted average price of sales of 63 shares of Company stock on November 16, 2026 at prices ranging from $965.38 to $965.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.

More REGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.